RegionsImunexus
Converting Antibodies into Bispecifics. Imunexus' technology facilitates rapid, cost-effective, lower risk, generation of effective therapeutics by converting existing monoclonal antibodies into multispecifics with additional therapeutic utility.
- 343, Royal Parade, 3052, 3052, Melbourne, Victoria
- http://www.imunexus.com
Type
Business Organisation
Imunexus
Business Organisation